CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-20 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +14,900 | $6.32 | $94K | 85,579 |
| 2020-04-20 | ROBINS HARLAN S Chief Scientific Officer | Sale | −2,000 | $27.72 | $55K | 83,579 |
| 2020-04-20 | ROBINS HARLAN S Chief Scientific Officer | Sale | −7,912 | $28.63 | $227K | 75,667 |
| 2020-04-20 | ROBINS HARLAN S Chief Scientific Officer | Sale | −4,988 | $29.58 | $148K | 70,679 |
| 2020-04-20 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −14,900 | 540,700 | ||
| 2020-04-20 | Cohen Chad M Chief Financial Officer | Option exercise | +10,000 | $4.07 | $41K | 11,000 |
| 2020-04-20 | Cohen Chad M Chief Financial Officer | Sale | −10,000 | $30.00 | $300K | 1,000 |
| 2020-04-20 | Cohen Chad M Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −10,000 | 20,000 | ||
| 2020-04-15 | ROBINS CHAD M CEO and Chairman | Option exercise | +11,120 | $0.33 | $4K | 1,889,300 |
| 2020-04-15 | ROBINS CHAD M CEO and Chairman | Sale | +500 | $27.62 | $14K | 1,888,800 |
| 2020-04-15 | ROBINS CHAD M CEO and Chairman | Sale | −10,620 | $28.34 | $301K | 1,878,180 |
| 2020-04-15 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −11,120 | 646,560 | ||
| 2020-04-14 | ROBINS CHAD M CEO and Chairman | Option exercise | +33,360 | $0.33 | $11K | 1,911,540 |
| 2020-04-14 | ROBINS CHAD M CEO and Chairman | Sale | −33,360 | $28.20 | $941K | 1,878,180 |
| 2020-04-14 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −33,360 | 657,680 | ||
| 2020-04-13 | ROBINS CHAD M CEO and Chairman | Option exercise | +5,560 | $0.33 | $2K | 1,883,740 |
| 2020-04-13 | ROBINS CHAD M CEO and Chairman | Sale | −1,500 | $24.83 | $37K | 1,882,240 |
| 2020-04-13 | ROBINS CHAD M CEO and Chairman | Sale | −900 | $25.62 | $23K | 1,881,340 |
| 2020-04-13 | ROBINS CHAD M CEO and Chairman | Sale | −3,160 | $26.74 | $84K | 1,878,180 |
| 2020-04-13 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −5,560 | 691,040 |
Page 109 of 120 · 2,386 trades